Dose-escalation | Clinical Trial Radar | MD Anderson Cancer Center

Trial Radar AI Trial Candidate or Patient Patient Caregiver Healthcare Pro Biotech Pro Biotech Investor Researcher Other
	Let's discuss and explore clinical trials with MD Anderson Cancer Center as a lead sponsor or collaborator. I can help you find nearby clinical trials and understand health conditions and treatments.

Let's discuss and explore clinical trials with MD Anderson Cancer Center as a lead sponsor or collaborator.

I can help you find nearby clinical trials and understand health conditions and treatments.

Study Title Translate	Status	Conditions	Enr.	Update	Other IDs	Start	Completion	Lead Sponsor	Collaborators	Sites	Phase
TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia NCT06088888	Recruiting	Chronic Myelogenous Leukemia	90	2/21/2025	TGRX-678-07-101	7/2/2024	6/30/2027	Shenzhen TargetRx, Inc.	M.D. Anderson Cancer Center	2	Phase 1
PIRATES: Image-guided Hyper-fractioned Dose-escalation With Proton Therapy for Head and Neck Cancer NCT06446713	Recruiting	Head and Neck CancerOropharyngeal Cancer	17	4/3/2025	PIRATES18646	5/1/2025	1/1/2029	University Medical Center Groningen	M.D. Anderson Cancer Center	1	Phase 1
Autologous CAR-T Cells Targeting B7-H3 in PDAC NCT06158139	Recruiting	Pancreas CancerRelapse	27	3/18/2025	LCCC2223-ATL	7/18/2024	6/1/2028	UNC Lineberger Comprehensive Cancer Center	M.D. Anderson Cancer Center	1	Phase 1
Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis NCT03594981	Recruiting	Viral Infection	36	8/28/2024	CHEERS	1/24/2018	11/1/2025	Catherine Bollard	M.D. Anderson Cancer Center	2	Phase 1Phase 2